David Griffin

Title: David Griffin: Innovator in Therapeutic Peptides

Introduction

David Griffin is a notable inventor based in Greenville, NC (US). He has made significant contributions to the field of therapeutic peptides, particularly with his innovative work on contulakin-G and its analogs. His research focuses on the potential applications of these peptides in treating various medical conditions.

Latest Patents

David Griffin holds a patent for "Contulakin-G, analogs thereof and uses therefor." This invention is directed to contulakin-G, a native glycosylated peptide, and its des-glycosylated form, Thr-contulakin-G. The patent also includes derivatives of these peptides and a cDNA clone encoding a precursor of the mature peptide. The therapeutic uses of this invention encompass a wide range of conditions, including anti-seizure, anti-inflammatory, and anti-psychotic applications, among others.

Career Highlights

David Griffin is affiliated with the University of Utah Research Foundation, where he continues to advance his research in peptide therapeutics. His work has the potential to impact various fields, including neurology and pharmacology. He has been recognized for his innovative approach to addressing complex medical issues through peptide technology.

Collaborations

David Griffin has collaborated with notable colleagues, including A Grey Craig and Baldomero M Olivera. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion

David Griffin's contributions to the field of therapeutic peptides highlight his innovative spirit and dedication to improving medical treatments. His work on contulakin-G and its applications demonstrates the potential of peptide technology in addressing a variety of health challenges.